US 9238069
Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment
granted A61KA61K31/047A61K31/16
Quick answer
US patent 9238069 (Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/047, A61K31/16, A61K31/568, A61K45/06